Presentation - What to control? CQAs and CPPs
2 |What to control?, BWP Workshop on Setting Specifications | Thomas Stangler, September 9th, 2011. Agenda Critical Quality Attributes …
Download Presentation - What to control? CQAs and CPPs
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
HIGH SPEED MACHINING (HSM) – THE EFFECTI VE …
fstroj.utc.sk—————————— International Workshop CA Systems And Technologies —————————— - 74 - The first category is industry which deals ...
毛髪の構造と物性の研究について
support.spring8.or.jp内容 ・原子間力顕微鏡(afm)と透過型電子顕微鏡 (tem)を用いた毛髪の微細構造観察について ・原子間力顕微鏡を用いた毛髪内部組織の 物性評価について
CIE/ISO new standard: CIEDE2000
www.color.orgCIE Division 1 . Vision and Colour. ISO Technical Committee 130 Graphic Technology. CIE/ISO new standard: CIEDE2000 University of Leeds (UK), 4 July 2013 (10:15 – 10:30)
2018 JAPAN - diajapan.org
www.diajapan.orgJULY 5th DIA Project Management Training Course for Clinical Study Sites JULY 21 | NIHONBASHI LIFE SCIENCE BUILDING 1st DIA Life Cycle Management Workshop in …
Regulatory Considerations for Peptide Drug Products
www.gphaonline.orgRegulatory Considerations for Peptide Drug Products Larisa C. Wu Peptide Team OGD/CDER/FDA 2013 GPhA/FDA CMC Workshop June 5, 2013 This presentation reflects the views of the author and
5 – Quality (CMC) considerations
www.ich.org1 5 – Quality (CMC) considerations Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD,
Qualitech Testing & Consultancy Limited 匯駿檢測 …
www.itc.gov.hkCALIBRATION AND MEASUREMENT CAPABILITY (CMC)* 校準和測量能力* Construction materials testing equipment - Cement grout flow cone Determination of the time of efflux of water 0.07 s
MARINE CORPS EXPLOSIVES SAFETY …
www.marines.milMCO 8020.10 10 JUN 2015 2 (x) AASTP-1, “Allied Ammunition Storage and . Transportation Publication,” May 2010 (y) AASTP-5 Allied, “Ammunition Storage and